X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
cancer (13) 13
microbiology (12) 12
humans (10) 10
beer (9) 9
biochemistry (9) 9
chemistry (9) 9
compositions or test papers therefor (9) 9
condition-responsive control in microbiological orenzymological processes (9) 9
enzymology (9) 9
human necessities (9) 9
hygiene (9) 9
immunotherapy (9) 9
measuring or testing processes involving enzymes, nucleicacids or microorganisms (9) 9
medical or veterinary science (9) 9
metallurgy (9) 9
microbiota (9) 9
mutation or genetic engineering (9) 9
preparations for medical, dental, or toilet purposes (9) 9
processes of preparing such compositions (9) 9
processes using microorganisms (9) 9
spirits (9) 9
vinegar (9) 9
wine (9) 9
animals (8) 8
health aspects (7) 7
tumors (7) 7
bacteria (6) 6
care and treatment (6) 6
intestinal microbiota (6) 6
life sciences (6) 6
neoplasms - therapy (6) 6
cyclophosphamide (5) 5
gut microbiota (5) 5
immunotherapy - methods (5) 5
lymphocytes (5) 5
mice (5) 5
neoplasms - drug therapy (5) 5
neoplasms - immunology (5) 5
neoplasms - microbiology (5) 5
anticancer properties (4) 4
dendritic cells (4) 4
immunology (4) 4
melanoma (4) 4
antibiotics (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antigens (3) 3
antineoplastic agents - therapeutic use (3) 3
antitumor immunity (3) 3
apoptosis (3) 3
cell receptors (3) 3
chemotherapy (3) 3
colorectal-cancer (3) 3
gastrointestinal microbiome - drug effects (3) 3
gastrointestinal microbiome - immunology (3) 3
inflammation (3) 3
ipilimumab (3) 3
lymphocytes t (3) 3
medical research (3) 3
medicine, research & experimental (3) 3
methods (3) 3
mice, inbred c57bl (3) 3
multidisciplinary sciences (3) 3
oncology (3) 3
pd-1 protein (3) 3
pd-l1 protein (3) 3
[ sdv ] life sciences [q-bio] (2) 2
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
adult (2) 2
article (2) 2
cancer therapies (2) 2
chain fatty-acids (2) 2
ctla-4 blockade (2) 2
cytotoxicity (2) 2
drug resistance, neoplasm (2) 2
effectiveness (2) 2
fecal microbiota transplantation (2) 2
female (2) 2
gastrointestinal microbiome - physiology (2) 2
gastrointestinal tract - microbiology (2) 2
immune checkpoint (2) 2
immune system (2) 2
immunologic memory (2) 2
intestine, small - microbiology (2) 2
intestines - microbiology (2) 2
ligands (2) 2
male (2) 2
medical prognosis (2) 2
metabolism (2) 2
metastasis (2) 2
microorganisms (2) 2
middle aged (2) 2
patients (2) 2
pd-1 blockade (2) 2
physiological aspects (2) 2
richness (2) 2
risk (2) 2
t cells (2) 2
t-cell responses (2) 2
t-lymphocytes - immunology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 11/2015, Volume 350, Issue 6264, pp. 1079 - 1084
Journal Article
Immunity, ISSN 1074-7613, 10/2016, Volume 45, Issue 4, pp. 931 - 943
Journal Article
Science, ISSN 0036-8075, 01/2018, Volume 359, Issue 6371, pp. 91 - 97
Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical responses in a sizable minority of cancer patients. We found that... 
CELL LUNG-CANCER | MELANOMA | MICROENVIRONMENT | INTESTINAL MICROBIOTA | CYCLOPHOSPHAMIDE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | GENES | RESISTANCE | ANTITUMOR IMMUNITY | NIVOLUMAB | CD4 Antigens - immunology | Immunotherapy - methods | Humans | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Gastrointestinal Microbiome - genetics | Fecal Microbiota Transplantation | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Metagenome - genetics | Neoplasms - therapy | Animals | Receptors, CCR - immunology | Interleukin-12 - immunology | Receptors, CXCR3 - immunology | T-Lymphocytes - immunology | Mice | Gastrointestinal Microbiome - immunology | Verrucomicrobia - genetics | Verrucomicrobia - immunology | Care and treatment | Cell receptors | Microbiota (Symbiotic organisms) | Immunotherapy | Epithelial tumors | Physiological aspects | Health aspects | Methods | Apoptosis | PD-1 protein | Interleukin | Microbiomes | Transplantation | Lymphocytes T | Anticancer properties | Microbiota | Lymphocytes | Bacteria | Feces | Supplementation | Gnotobiotics | Kidneys | Melanoma | Dietary supplements | Interleukin 12 | Abundance | CXCR3 protein | Patients | CD4 antigen | Immune checkpoint | Antibiotics | Lungs | Flora | PD-L1 protein | Relative abundance | Antitumor activity | CCR9 protein | Tumors | Kidney transplantation | Cancer | Life Sciences
Journal Article
Science, ISSN 0036-8075, 11/2013, Volume 342, Issue 6161, pp. 971 - 976
Journal Article
Science Translational Medicine, ISSN 1946-6234, 01/2015, Volume 7, Issue 271, pp. 271ps1 - 271ps1
Changes in the interactions among the gut microbiota, intestinal epithelium, and host immune system are associated with many diseases, including cancer. We... 
MEDICINE, RESEARCH & EXPERIMENTAL | TRANSLOCATION | BACTERIA | THERAPY | INTESTINAL MICROBIOTA | COLORECTAL-CANCER | INFLAMMATION | DISEASE | LIVER | RISK | PROBIOTICS | CELL BIOLOGY | Carcinogenesis - pathology | Microbiota | Humans | Neoplasms - microbiology | Gastrointestinal Tract - microbiology | Antineoplastic Agents - therapeutic use | Dysbiosis | Neoplasms - drug therapy
Journal Article
Immunity, ISSN 1074-7613, 06/2016, Volume 44, Issue 6, pp. 1255 - 1269
Journal Article